# PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

> **NCT00019565** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 53 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** positron emission tomography
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT00019565
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2008-08
- **Final completion:** —
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019565, "PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00019565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*